Interpersonal Psychotherapy for Severely Depressed Inpatients
Status:
Terminated
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
We examined the hypotheses that severely depressed inpatients treated for 5 weeks with IPT-S
plus pharmacotherapy have 1) a higher reduction in depressive symptoms and 2) higher
response- and remission rates compared to pharmacotherapy plus CM. For the follow-up period
(12 months) we hypothesized a better symptomatic and psychosocial longterm outcome and lower
rates of relapse for patients initially treated with combination therapy.
Phase:
N/A
Details
Lead Sponsor:
German Research Foundation
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination Sertraline